Medical advisory board

Dr Mackay trained as a Consultant Medical Oncologist with a special interest in cancer genetics at Trinity College Cambridge and the University of Edinburgh Medical School.

He established the NHS Cancer Genetics Services in East Anglia at Addenbrooke’s Hospital and North-East Thames at Great Ormond Street, leaving the NHS in 2006 to establish a private practice.

Dr Mackay is an Honorary Senior Lecturer in the Research Department of Oncology at University College London. He is involved with a number of national cancer charities. Having worked with several commercial genetic testing companies over the last few years, he now serves as Everything Genetic’s Medical Director.

Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, having developed a highly regarded clinical service for cancer genetics in the North West.

He is a Consultant at the Central Manchester Hospitals NHS Foundation Trust, The Christie NHS Foundation Trust and is a lead clinician on the NICE familial breast cancer guideline group and a Trustee of BCN and the Neuro Foundation.

Professor Evans also serves as Chief Investigator on two NIHR program grants (2009-2014, £1.59 million) (2017-2020, £1million) on breast cancer risk prediction and has an NIHR RfPB grant as CI (2011). He has led the successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service.

Evans has published 915 peer reviewed research publications and has an ISI web of knowledge H-index of 90, and Google scholar of 123 having only published his first article in 1990.

A Professor at Wolfson Institute of Population Health, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts and the Royal London Hospital.

Manchanda led the research on the PROMISE Pilot study to help understand the feasibility of population-based risk prediction and stratification for targeting ovarian cancer and was involved in the RRESDO study for cancer diagnostics.

He is co-Lead for the Cancer Prevention Theme at the Barts CRUK Cancer Centre, and appointed as Speciality Research Lead for Gynaecological Cancer, NIHR North Thames Clinical Research Network (CRN). He is the Integrated Academic Training Programme Director, London Speciality School of Obstetrics & Gynaecology, Health Education England. He also leads the RCOG Advanced Professional Module (APM) in Clinical Research for North Central and North East London.

Professor Manchanda is a member of the International Gynaecological Cancer Society (IGCS) Education Steering Committee. He has led several training initiatives in Gynaecological Oncology across Europe. He has served as President of the European Network of Young Gynaecological Oncologists (ENYGO) and member of the European Society of Gynaecological Oncology (ESGO) Council from 2011-2013.